Working… Menu

A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03395704
Recruitment Status : Active, not recruiting
First Posted : January 10, 2018
Last Update Posted : July 30, 2019
PRA Health Sciences
Information provided by (Responsible Party):
La Jolla Pharmaceutical Company

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : October 2019